Neogen (NEOG) Competitors $5.74 +0.11 (+1.95%) Closing price 08/27/2025 04:00 PM EasternExtended Trading$5.74 0.00 (0.00%) As of 08/27/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. ICUI, XRAY, HAE, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors ICU Medical DENTSPLY SIRONA Haemonetics QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Neogen (NASDAQ:NEOG) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations. Does the media prefer NEOG or ICUI? In the previous week, Neogen had 35 more articles in the media than ICU Medical. MarketBeat recorded 44 mentions for Neogen and 9 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.63 beat Neogen's score of 0.30 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 11 Very Positive mention(s) 0 Positive mention(s) 24 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral ICU Medical 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is NEOG or ICUI more profitable? ICU Medical has a net margin of -1.56% compared to Neogen's net margin of -122.06%. ICU Medical's return on equity of 7.24% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-122.06% 2.39% 1.57% ICU Medical -1.56%7.24%3.50% Do analysts rate NEOG or ICUI? Neogen currently has a consensus price target of $7.50, indicating a potential upside of 30.66%. ICU Medical has a consensus price target of $179.00, indicating a potential upside of 41.37%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than Neogen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25ICU Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in NEOG or ICUI? 96.7% of Neogen shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 1.1% of Neogen shares are owned by insiders. Comparatively, 1.5% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has preferable earnings and valuation, NEOG or ICUI? ICU Medical has higher revenue and earnings than Neogen. ICU Medical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$894.66M1.39-$1.09B-$5.03-1.14ICU Medical$2.38B1.31-$117.69M-$1.52-83.30 Which has more volatility and risk, NEOG or ICUI? Neogen has a beta of 1.79, suggesting that its share price is 79% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. SummaryICU Medical beats Neogen on 12 of the 17 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.22B$10.71B$5.79B$9.78BDividend YieldN/A1.86%3.95%4.02%P/E Ratio-1.1421.2030.8326.37Price / Sales1.3931.87460.97120.29Price / Cash0.9824.9437.7659.36Price / Book0.603.5010.186.62Net Income-$1.09B$210.11M$3.26B$265.42M7 Day Performance2.50%4.70%2.79%3.08%1 Month Performance5.90%11.78%3.95%0.77%1 Year Performance-65.87%-6.50%44.12%22.97% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.6441 of 5 stars$5.74+2.0%$7.50+30.7%-66.6%$1.22B$894.66M-1.142,110Trending NewsICUIICU Medical4.6836 of 5 stars$125.81-1.8%$179.00+42.3%-22.8%$3.16B$2.38B21.5415,000Positive NewsInsider TradeXRAYDENTSPLY SIRONA4.9941 of 5 stars$14.40-1.8%$18.64+29.4%-43.6%$2.92B$3.79B8.5714,000News CoveragePositive NewsHAEHaemonetics4.9524 of 5 stars$55.30-1.9%$85.18+54.0%-28.2%$2.72B$1.36B12.123,023Trending NewsAnalyst RevisionQDELQuidelOrtho4.325 of 5 stars$27.65-0.9%$42.17+52.5%-37.4%$1.89B$2.78B11.926,600STAASTAAR Surgical2.2159 of 5 stars$27.49-1.3%$20.67-24.8%-15.0%$1.38B$313.90M0.001,211Positive NewsCERSCerus2.9414 of 5 stars$1.28+1.2%$3.50+173.4%-43.5%$242.50M$180.27M0.00290Positive NewsOSUROraSure Technologies2.2756 of 5 stars$3.14+4.7%$3.00-4.5%-23.7%$219.41M$185.83M0.00840High Trading VolumeUTMDUtah Medical Products2.5527 of 5 stars$60.34-1.0%N/A-10.1%$195.37M$40.90M16.30180News CoveragePositive NewsDividend AnnouncementGap DownANIKAnika Therapeutics4.3781 of 5 stars$9.13-5.4%$18.00+97.2%-63.3%$139.13M$119.91M0.00300WSTWest Pharmaceutical Services4.7318 of 5 stars$246.98-0.4%$320.71+29.9%-18.7%$17.82B$2.89B35.6110,600Positive News Related Companies and Tools Related Companies ICUI Competitors XRAY Competitors HAE Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access